跳至主要内容
临床试验/CTRI/2024/07/070813
CTRI/2024/07/070813尚未招募Unknown

Effectiveness and Tolerability of Low-Dose Micronized-Isotretinoin in Patients with Severe Recalcitrant Nodular Facial Acne: A Real-World Retrospective Study from Electronic Medical Records - NI

Sun Pharmaceutical Industries Ltd. (SPIL)0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Male or female greater than equal to 12 years of age
  • 2. Patients diagnosed with severe recalcitrant nodular facial acne by treating dermatologist
  • 3. Patient who completed at least 8 weeks of therapy with low dose micronized-isotretinoin (Sotret® NF)

排除标准

  • 1. Pregnant and lactating females
  • 2. Patient who had already taken conventional or micronized isotretinoin in the past
  • 3. Known hypersensitivity to isotretinoin

研究者

发起方
Sun Pharmaceutical Industries Ltd. (SPIL)

相似试验